Cingulate Inc. Proceeds from Long-Term Debt Issued
Cingulate Inc. (CING) reported Proceeds from Long-Term Debt Issued of $3.00 million for the 1-month period ending 2023-05-31, per its 10-K filed 2025-03-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2025-03-27
- 2023-05-31: Proceeds from Issuance of Long-term Debt 1 month $3.00M.
- 2023-05-09: Proceeds from Issuance of Long-term Debt $3.00M.
| Period end | Proceeds from Issuance of Long-term Debt | Proceeds from Issuance of Long-term Debt 1 month |
|---|---|---|
| 2023-05-31 | $3.00M 10-K · filed 2025-03-27 | |
| 2023-05-09 | $3.00M 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |